Jason Drew Smith, General Counsel: UroGen Pharma URGN Sell · Filed 25/09/09

Trade details

Type: Insider sale
Amount: $29,047.2
Shares · price: 1,520 sh · $19.11 a share
Held after: 43,305 sh
Stock: UroGen Pharma URGN
Person: Jason Drew SmithGeneral Counsel
Trade date: 25/09/08
Filed: 25/09/09
Days to filing: 1 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

UroGen Pharma trades, last 26 weeks

What else happened in UroGen Pharma around then

Filed or reported within 30 days of the trade day · 25/08/09~25/10/08

Jason Drew Smith's recent trades

Jason Drew SmithGeneral Counsel
Planned saleUroGen Pharma
Planned sale
UroGen Pharma
URGN
$67K
1,519 sh
$67K
Filed 09/09
Traded 09/08
Jason Drew SmithGeneral Counsel
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$63.3K
3,217 sh
$63.3K
Filed 02/11
Traded 02/03
Jason Drew SmithGeneral Counsel
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$52.3K
2,654 sh
$52.3K
Filed 02/11
Traded 02/03
Jason Drew SmithGeneral Counsel
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$31.7K
1,608 sh
$31.7K
Filed 02/11
Traded 02/03
Jason Drew SmithGeneral Counsel
Planned saleUroGen Pharma
Planned sale
UroGen Pharma
URGN
$28.7K
1,520 sh
$28.7K
Filed 25/09/09
Traded 25/09/08